Skip to main content

Animations

MJFF Publications

2061 - 2070 of 8823 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Large‐scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.14360
    Citation Count: 38
  • Summary Details
    OPEN
    Title: NLRP3 Inflammasome Activation and Altered Mitophagy Are Key Pathways in Inclusion Body Myositis
    Journal Name: Journal of Cachexia, Sarcopenia and Muscle
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/jcsm.13672
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.30019
    Citation Count: 21
  • Summary Details
    OPEN
    Title: A highly efficient, scalable pipeline for fixed feature extraction from large-scale high-content imaging screens
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.isci.2024.111434
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Opto-Avoidance-Elevated Plus Maze protocol to study positive or negative valence upon optogenetic stimulation in the mouse brain
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.xpro.2024.103474
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Multimodal oculomotor assessment reveals prodromal markers of Parkinson’s disease in non-manifesting LRRK2 G2019S mutation carriers
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00840-w
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Brain age in genetic and idiopathic Parkinson's disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae382
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson’s disease risk
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s43587-024-00760-7
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2412029122
    Citation Count: 12
  • Summary Details
    OPEN
    Title: The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241310722
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.